E. coli engineered to produce important class of antibiotic, anti-cancer drugs

Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have taken a major step forward in the field of metabolic engineering, successfully using the bacterium Escherichia coli to synthesize a class of natural products known bacterial aromatic polyketides, which include important antibiotic and anticancer drugs.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news149179802.html">E. coli engineered to produce important class of antibiotic, anti-cancer drugs</a></p> <p>Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have taken a major step forward in the field of metabolic engineering, successfully using the bacterium <I>Escherichia coli</I> to synthesize a class of natural products known bacterial aromatic polyketides, which include important antibiotic and anticancer drugs.</p>